Guardant Health, Inc.: Guardant Health Receives EU IVDR Cert

Blood-based test for comprehensive genomic profiling of solid cancers meets requirements under stricter EU In Vitro Diagnostic Regulation IVDR certification from TÜV SÜD enables broader adoption

Related Keywords

Meldola , Emilia Romagna , Italy , Germany , Michael Weist , Nicola Normanno , Zarak Khurshid , Dino Amadori , Helmy Eltoukhy , Peter Fasching , Gynecological Cancer Center , Nasdaq , Cancer Center , Guardant Health Inc , National Comprehensive Cancer Network , Facebook , Exchange Commission , Linkedin , European Union In Vitro Diagnostic Regulation , Breast Cancer Center , Guardant Health , D Product Service , Romagna Institute For The Study Of Tumors , European Union , Vitro Diagnostic Regulation , Comprehensive Cancer Center , Financial Condition , Annual Report , Bangy J , Safety Data , Positive Advanced Non Small Cell Lung Cancer , Global Phase , Next Generation Sequencing , Non Small Cell Lung , Molecular Analyses Guide Efforts , Prospective Study , Molecular Profiling , Metastatic Triple Negative Breast , Circulating Tumor , Matched Metastatic Tissue Biopsy , Ihr Portfolio ,